Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications for weight management and Type 2 diabetes. Find the cheapest way to get your prescription.
We’ll email you when new manufacturer programs, coupons, or telehealth options become available for your medications.
No spam. Unsubscribe anytime.
Online telehealth providers prescribe GLP-1 medications for a fraction of retail — often without insurance. Compare providers or find your best option.
Licensed US providers · No insurance required · HSA/FSA eligible
SaveRx.ai earns a commission on purchases made through affiliate links. This does not affect editorial content.
GLP-1 receptor agonists are the most prescribed weight-loss medications today. They work by slowing digestion and reducing appetite. Savings are complicated — most insurance plans don’t cover GLP-1s specifically for weight loss, and copay cards often have strict eligibility rules.
For Type 2 diabetes patients: Ozempic, Rybelsus, and Trulicity are FDA-approved for T2D and more commonly covered by insurance. Manufacturer savings cards can bring costs down to $25–$99/month for commercially insured patients.
For weight loss without insurance: Online GLP-1 providers like Embody GLP1, Hims & Hers, and Ro Body offer compounded alternatives starting around $145–$349/month with a telehealth consultation included.
Most commercial insurance plans do NOT cover GLP-1s (like Ozempic or Wegovy) specifically for weight loss. Ozempic may be covered for Type 2 diabetes. Wegovy and Zepbound are FDA-approved for obesity and covered by some plans. Always check your formulary and ask your prescriber to use the correct diagnosis code.
Ozempic retails for approximately $968/month and Wegovy for approximately $1,349/month without insurance. With manufacturer savings cards for commercially insured patients, costs may be reduced to $25/month. Uninsured patients may qualify for patient assistance or telehealth providers offering alternatives starting around $145/month.
For insured patients: use the manufacturer savings card (Novo Nordisk for Ozempic/Wegovy, Eli Lilly for Mounjaro/Zepbound). For uninsured patients: online telehealth providers offer compounded GLP-1 alternatives at $145–$349/month. Compare all options at our GLP-1 telehealth comparison page.
Compounded semaglutide and tirzepatide have been available through FDA-registered 503B compounding pharmacies. Compounded drugs held to sterility and potency standards differ from FDA-approved branded drugs. They are not FDA-approved. Always consult your prescriber and get a legitimate prescription from a licensed telehealth provider.